Dow Q3 2025: Struggling at the Bottom of the Cycle Amid a Slow Structural Recovery

Dow Inc. released its third-quarter 2025 results on October 23, showing continued weakness across all business segments. Although sequential performance improved slightly, the year-on-year declines remain significant, underscoring persistent demand weakness, pricing pressure, and high input costs.

Key takeaway: Dow remains under broad cyclical pressure, yet stronger cash flow and lower costs signal early signs of operational stabilization.

Packaging & Specialty Plastics: Profits Halved but Margins Recover Sequentially

This segment, Dow’s largest revenue contributor, faced a sharp profitability squeeze as polyethylene and polymer prices fell 10% year over year, alongside lower licensing revenue.

Sequentially, however, Operating EBIT rose sharply, driven by the new polyethylene unit in Freeport, Texas, higher utilization, and improved cost efficiency. Flexible packaging demand showed resilience, cushioning part of the decline, while supply disruptions at the Sadara JV have now normalized.

Industrial Intermediates & Infrastructure: Resilient Through Efficiency Gains 

The Industrial Intermediates & Infrastructure (II&I) segment performed more steadily, supported by North American demand recovery and the new alkylation unit in Seadrift, Texas. While still loss-making, EBIT improved significantly quarter-over-quarter, reflecting lower maintenance downtime and improved plant efficiency.

Nevertheless, JV losses in Kuwait and Sadara widened, underscoring structural margin pressure in high-cost regions.

Performance Materials & Coatings: Margin Compression Persists

Weakness in siloxanes and seasonal declines in coating applications weighed on profitability. Although fixed costs were reduced, EBIT margin erosion continued, reflecting softer consumer solutions demand and margin compression in upstream silicones. Dow plans further optimization of its high-value coatings and silicone product mix through 2026 to restore profitability.

Financial & Strategic Highlights

Dow’s revenue decline remains primarily price-driven: local prices dropped 8% year-on-year, while volumes declined 1%. EMEAI weakness was partially offset by gains in North America and Asia-Pacific. Sequentially, volumes rose 1%, signaling inventory normalization across the chain. 

Operating EBIT fell $461M YoY, while EBITDA decreased $514M, but both metrics improved sequentially, supported by cost reduction initiatives.

GAAP EPS came in at $0.08 (vs. $0.30 YoY), and operating EPS at -$0.19, compared to $0.47 last year.

Notably, Dow recorded a one-time gain from divesting its 50% stake in the DowAksa JV and a favorable tax adjustment, mitigating part of the earnings decline.

Cash flow from operations rose 41% YoY to $1.13B, reflecting improved working capital efficiency and disciplined capital spending — a crucial signal of liquidity strength amid a weak profit cycle.

Outlook: Building a Floor, Not Yet a Turning Point

Dow’s Q3 results reflect a classic “bottoming” phase — sequential progress, but far from recovery. The global chemical industry remains in a late-stage destocking cycle, with subdued downstream demand and weak pricing power. 

Operationally, Dow’s Gulf Coast investments are beginning to pay off, supporting volume recovery and lowering unit costs. If polyethylene and alkoxylation assets sustain utilization gains through 1H26, the company could emerge from the downturn earlier than peers.

However, Europe’s high-cost footprint and JV profitability erosion remain structural drags. In essence, Dow is in a cash restoration phase, not yet a profit inflection phase. True recovery will depend on global demand revival and further portfolio optimization. 

Bottom line: Dow is stabilizing operationally but not yet growing financially. The company is managing through the trough — relying on cost discipline and capital efficiency — while waiting for the next upcycle to reignite margin expansion.